HomeRVNC • NASDAQ
add
Revance Therapeutics Inc
Previous close
$3.84
Day range
$3.69 - $3.90
Year range
$2.30 - $9.74
Market cap
391.29M USD
Avg Volume
2.28M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 59.88M | 10.66% |
Operating expense | 63.12M | -4.60% |
Net income | -38.12M | 73.00% |
Net profit margin | -63.65 | 75.60% |
Earnings per share | -0.37 | 30.29% |
EBITDA | -31.00M | 12.51% |
Effective tax rate | -4.10% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 184.08M | -38.69% |
Total assets | 461.56M | -13.32% |
Total liabilities | 624.59M | -2.21% |
Total equity | -163.03M | — |
Shares outstanding | 104.90M | — |
Price to book | -2.48 | — |
Return on assets | -16.86% | — |
Return on capital | -23.64% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -38.12M | 73.00% |
Cash from operations | -41.09M | 19.37% |
Cash from investing | 23.29M | -54.85% |
Cash from financing | -6.09M | -116.25% |
Net change in cash | -23.88M | -162.71% |
Free cash flow | -53.62M | -45.42% |
About
Founded
1999
Headquarters
Website
Employees
597
